[New therapeutics in the suppression of superficial bladder carcinoma].
Bartoletti
Riccardo
R
Clinica Urologica Università di Firenze, Divisione di Urologia Ospedale S. Maria Annunziata, Firenze. riccardo.bartoletti@unifi.it
Cai
Tommaso
T
Mondaini
Nicola
N
Farina
Umberto
U
Melone
Franco
F
Mazzoli
Sandra
S
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000283:Administration, Intravesical; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001500:BCG Vaccine / Q000627:therapeutic use; D002291:Carcinoma, Papillary / Q000628:therapy*; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D015251:Epirubicin / Q000008:administration & dosage; D006801:Humans; D016685:Mitomycin / Q000008:administration & dosage; D016896:Treatment Outcome; D001749:Urinary Bladder Neoplasms / Q000628:therapy*; D000093542:Gemcitabine
D000276:Adjuvants, Immunologic; D001500:BCG Vaccine; D003841:Deoxycytidine; D015251:Epirubicin; D016685:Mitomycin; D000093542:Gemcitabine